Marc Alvarez, DPM
Podiatrist · Tallahassee, FLNPI 1710515317
Payments from drug & device makers
Across 67 payments — averaging $85.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nvision Biomedical Technologies, Inc.$2K
- CGG Medical Inc$1K
- Arthrex$1K
- Integra Lifesciences Corporation$400
- Kerecis Limited$218
- Stryker$211
- plus $643 from 12 others
What the payments were for
- Travel & lodging$2,99252%
- Food & beverage$2,41942%
- Other$3005%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nvision Biomedical Technologies, Inc. | 4 | $1,915 |
| CGG Medical Inc | 20 | $1,301 |
| Arthrex | 12 | $1,023 |
| Integra Lifesciences Corporation | 3 | $400 |
| Kerecis Limited | 5 | $218 |
| Stryker | 4 | $211 |
| Convatec Inc. | 3 | $167 |
| Orthofix Medical, Inc. | 1 | $129 |
| Smith+Nephew | 5 | $119 |
| Trice Medical, Inc. | 1 | $47 |
| Organogenesis Inc. | 2 | $43 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Mimedx Group, Inc. | 1 | $24 |
| Crossroads Orthopedics, LLC | 1 | $23 |
| Biowound Solutions, Inc. | 1 | $20 |
| Treace Medical Concepts, Inc. | 1 | $20 |
| Medline Industries LP | 1 | $14 |
| Arteriocyte Medical Systems, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Foot and Ankle$1,762
- Kerecis Omega3 Marigen$463
- TCC-EZ$300
- Physio-Stim$257
- Foot & Ankle Device$153
- InnovaMatrix AC$151
- LIMFLOW SYSTEM$140
- Kerecis Omega3 SurgiClose$116
How this compares
$5,711 in reported general payments places this provider in the 80th percentile of 588 podiatrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 42 | $1,225 |
| Ciclopirox | 24 | $893 |
| Ketoconazole | 29 | $644 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 61 | $382 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 45 | $370 |
| Gabapentin | 14 | $207 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $206 |
| Cephalexin | 31 | $156 |
| Methylprednisolone | 16 | $114 |
| Meloxicam | 13 | $60 |
| Ibuprofen | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Tallahassee
- Joshua NicholsTallahassee$30K
- James CottomSarasota$1.9M
- Desmond BellJacksonville$365K
- Caroline KiserFleming Island$206K
- Adam PerlerLargo$160K
- Jeffrey KarrLakeland$101K
- Marie WilliamsAventura$96K
- Todd BrennanTampa$88K
- Robert HooverLake Mary$71K
- Daniel BrandweinPompano Beach$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.